Literature DB >> 2326776

Local prevention of thrombosis in animal arteries by means of magnetic targeting of aspirin-loaded red cells.

N M Orekhova1, R S Akchurin, A A Belyaev, M D Smirnov, S E Ragimov, A N Orekhov.   

Abstract

Thrombosis was induced in 18 dog and 16 rabbit arteries by surgically inverting a vascular wall flap into its lumen. A completely occluding red thrombus was formed inside the vessel 4 to 5 hours later in 80% of cases. SmCo5 magnet was secured externally to one of the arteries. The constant magnetic field produced by the magnet had no influence on the clot formation. Autologous red cells loaded with ferromagnetic colloid compound and aspirin were administered intravenously and completely aborted arteriothrombosis on magnet-supplied side with no deterioratory effect on clot formation in the control artery.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2326776     DOI: 10.1016/0049-3848(90)90078-q

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  The Behaviors of Ferro-Magnetic Nano-Particles In and Around Blood Vessels under Applied Magnetic Fields.

Authors:  A Nacev; C Beni; O Bruno; B Shapiro
Journal:  J Magn Magn Mater       Date:  2011-03-01       Impact factor: 2.993

2.  Magnetic nanoparticle transport within flowing blood and into surrounding tissue.

Authors:  A Nacev; C Beni; O Bruno; B Shapiro
Journal:  Nanomedicine (Lond)       Date:  2010-11       Impact factor: 5.307

Review 3.  Magnetic nanoparticle drug carriers and their study by quadrupole magnetic field-flow fractionation.

Authors:  P Stephen Williams; Francesca Carpino; Maciej Zborowski
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

Review 4.  Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.

Authors:  Carlos H Villa; Aaron C Anselmo; Samir Mitragotri; Vladimir Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2016-03-03       Impact factor: 15.470

5.  Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compounds.

Authors:  Caterina Cinti; Monia Taranta; Ilaria Naldi; Settimio Grimaldi
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

Review 6.  Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery.

Authors:  Joan Estelrich; Elvira Escribano; Josep Queralt; Maria Antònia Busquets
Journal:  Int J Mol Sci       Date:  2015-04-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.